Literature DB >> 31439615

Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Charles S Tannenbaum1, Patricia A Rayman1, Paul G Pavicic1, Jin Sub Kim1, Wei Wei2, Alexandra Polefko1, Wesley Wallace1, Brian I Rini2, Gareth Morris-Stiff3, Daniela S Allende4, Thomas Hamilton1, James H Finke1, C Marcela Diaz-Montero5.   

Abstract

Myeloid-derived suppressor cells (MDSC) are induced by and accumulate within many histologically distinct solid tumors, where they promote disease by secreting angiogenic and immunosuppressive molecules. Although IL1β can drive the generation, accumulation, and functional capacity of MDSCs, the specific IL1β-induced inflammatory mediators contributing to these activities remain incompletely defined. Here, we identified IL1β-induced molecules that expand, mobilize, and modulate the accumulation and angiogenic and immunosuppressive potencies of polymorphonuclear (PMN)-MDSCs. Unlike parental CT26 tumors, which recruited primarily monocytic (M)-MDSCs by constitutively expressing GM-CSF- and CCR2-directed chemokines, IL1β-transfected CT26 produced higher G-CSF, multiple CXC chemokines, and vascular adhesion molecules required for mediating infiltration of PMN-MDSCs with increased angiogenic and immunosuppressive properties. Conversely, CT26 tumors transfected with IL1β-inducible molecules could mobilize PMN-MDSCs, but because they lacked the ability to upregulate IL1β-inducible CXCR2-directed chemokines or vascular adhesion molecules, additional PMN-MDSCs could not infiltrate tumors. IL1β-expressing CT26 increased angiogenic and immunosuppressive factors of tumor-infiltrating MDSCs, as did CT26 tumors individually transfected with G-CSF, Bv8, CXCL1, or CXCL5, demonstrating that mediators downstream of IL1β could also modulate MDSC functional activity. Translational relevance was indicated by the finding that the same growth factors, cytokines, chemokines, and adhesion molecules responsible for the mobilization and recruitment of PMN-MDSCs into inflammatory CT26 murine tumors were also coordinately upregulated with increasing IL1β expression in human renal cell carcinoma tumors. These studies demonstrated that IL1β stimulated the components of a multifaceted inflammatory program that produces, mobilizes, chemoattracts, activates, and mediates the infiltration of PMN-MDSCs into inflammatory tumors to promote tumor progression. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31439615      PMCID: PMC6774821          DOI: 10.1158/2326-6066.CIR-18-0578

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  50 in total

Review 1.  Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.

Authors:  C Marcela Diaz-Montero; Jim Finke; Alberto J Montero
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

2.  Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.

Authors:  Yana G Najjar; Patricia Rayman; Xuefei Jia; Paul G Pavicic; Brian I Rini; Charles Tannenbaum; Jennifer Ko; Samuel Haywood; Peter Cohen; Thomas Hamilton; C Marcela Diaz-Montero; James Finke
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

3.  Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

Authors:  B A Pulaski; S Ostrand-Rosenberg
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

4.  Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.

Authors:  Bhawna Sharma; Kalyan C Nannuru; Michelle L Varney; Rakesh K Singh
Journal:  Clin Exp Metastasis       Date:  2014-12-16       Impact factor: 5.150

Review 5.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 6.  Cancer as an overhealing wound: an old hypothesis revisited.

Authors:  Matthias Schäfer; Sabine Werner
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-16       Impact factor: 94.444

Review 7.  Multi-faceted roles for CXC-chemokines in prostate cancer progression.

Authors:  David J J Waugh; Catherine Wilson; Angela Seaton; Pamela J Maxwell
Journal:  Front Biosci       Date:  2008-05-01

Review 8.  EG-VEGF and Bv8: a novel family of tissue-restricted angiogenic factors.

Authors:  Napoleone Ferrara; Jennifer LeCouter; Rui Lin; Franklin Peale
Journal:  Biochim Biophys Acta       Date:  2004-03-04

9.  Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression.

Authors:  Scott I Abrams; Jeremy D Waight
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110

10.  Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.

Authors:  Alexandra Sevko; Viktor Umansky
Journal:  J Cancer       Date:  2012-11-30       Impact factor: 4.207

View more
  11 in total

1.  The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.

Authors:  Defne Bayik; Juyeun Lee; Justin D Lathia
Journal:  Exp Suppl       Date:  2022

Review 2.  Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.

Authors:  Shweta Joshi; Andrew Sharabi
Journal:  Pharmacol Ther       Date:  2022-02-02       Impact factor: 13.400

3.  Impact of losing adipose tissue on outcomes from PD-1/PD-L1 inhibitor monotherapy in non-small cell lung cancer.

Authors:  Naoya Nishioka; Tateaki Naito; Taichi Miyawaki; Michitoshi Yabe; Kosei Doshita; Hiroaki Kodama; Eriko Miyawaki; Yuko Iida; Nobuaki Mamesaya; Haruki Kobayashi; Shota Omori; Ryo Ko; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Haruyasu Murakami; Koichi Takayama; Toshiaki Takahashi
Journal:  Thorac Cancer       Date:  2022-04-14       Impact factor: 3.223

Review 4.  Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets.

Authors:  Yan Tie; Fan Tang; Yu-Quan Wei; Xia-Wei Wei
Journal:  J Hematol Oncol       Date:  2022-05-18       Impact factor: 23.168

Review 5.  Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection.

Authors:  Fan Tang; Yan Tie; Weiqi Hong; Yuquan Wei; Chongqi Tu; Xiawei Wei
Journal:  Ann Surg Oncol       Date:  2020-11-30       Impact factor: 5.344

6.  Obesity diminishes response to PD-1-based immunotherapies in renal cancer.

Authors:  Shannon K Boi; Rachael M Orlandella; Justin Tyler Gibson; William James Turbitt; Gal Wald; Lewis Thomas; Claire Buchta Rosean; Katlyn E Norris; Megan Bing; Laura Bertrand; Brett P Gross; Amani Makkouk; Dmytro Starenki; Kristine I Farag; Robert E Sorge; James A Brown; Jennifer Gordetsky; Hesham Yasin; Rohan Garje; Lakshminarayanan Nandagopal; George J Weiner; David M Lubaroff; Rebecca C Arend; Peng Li; Yousef Zakharia; Eddy Yang; Aliasger K Salem; Kenneth Nepple; Tatiana T Marquez-Lago; Lyse A Norian
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

Review 7.  Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer.

Authors:  Kai Li; Houhui Shi; Benxia Zhang; Xuejin Ou; Qizhi Ma; Yue Chen; Pei Shu; Dan Li; Yongsheng Wang
Journal:  Signal Transduct Target Ther       Date:  2021-10-07

Review 8.  Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation.

Authors:  Chiel van Geffen; Constantin Heiss; Astrid Deißler; Saeed Kolahian
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

9.  Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses.

Authors:  David H Aggen; Casey R Ager; Aleksandar Z Obradovic; Nivedita Chowdhury; Ali Ghasemzadeh; Wendy Mao; Matthew G Chaimowitz; Zoila A Lopez-Bujanda; Catherine S Spina; Jessica E Hawley; Matthew C Dallos; Cheng Zhang; Vinson Wang; Hu Li; Xinzheng V Guo; Charles G Drake
Journal:  Clin Cancer Res       Date:  2020-11-04       Impact factor: 13.801

10.  Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout.

Authors:  Limei Zhong; Sitao Li; Yi Wen; Junhui Zheng; Fengbin Liu; Donglin Cao; Yufeng Liu
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.